{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:10:51Z","timestamp":1790809851319,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.contraception.2007.11.003","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T09:50:12Z","timestamp":1205401812000},"page":"249-256","source":"Crossref","is-referenced-by-count":64,"title":["Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"77","author":[{"given":"William","family":"Koltun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Lucky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Niknian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Sampson-Landers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Korner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2007.11.003_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00128071-200203080-00007","article-title":"Acne: effect of hormones on pathogenesis and management","volume":"3","author":"Shaw","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.contraception.2007.11.003_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0733-8635(05)70418-6","article-title":"Acne. An overview of clinical research findings","volume":"15","author":"Thiboutot","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.contraception.2007.11.003_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2007.11.003_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current concepts of the pathogenesis of acne: implications for drug treatment","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2007.11.003_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0015-0282(16)53212-9","article-title":"Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women","volume":"53","author":"Murphy","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2007.11.003_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(90)90034-S","article-title":"Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone","volume":"41","author":"van der Vange","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.003_bib7","first-page":"123","article-title":"Superiority of a combined oral contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2007.11.003_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.003_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 4","key":"10.1016\/j.contraception.2007.11.003_bib10","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2007.11.003_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 mcg ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.003_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 mcg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.003_bib13","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1097\/00006250-200604001-00115","article-title":"Ovulation inhibition effects of two low-dose OC dosing regimens following intentional dosing errors","volume":"107","author":"Klipping","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.003_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.003_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.003_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.003_bib17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2007.11.003_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 mcg of ethinyl estradiol and 200 mcg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2007.11.003_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2007.11.003_bib20","article-title":"Drospirenone 3 mg\/ethinylestradiol 20 mcg COC in the Treatment of acne vulgaris: lesion count, ISGA","author":"Maloney","year":"2007"},{"key":"10.1016\/j.contraception.2007.11.003_bib21","article-title":"Drospirenone 3 mg\/ethinylestradiol 20 mcg COC in the treatment of acne vulgaris: Investigator and subject self-assessment","author":"Maloney","year":"2007"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407005008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407005008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T21:27:54Z","timestamp":1546205274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782407005008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0010782407005008"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2007.11.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}